Page 1214 - Williams Hematology ( PDFDrive )
P. 1214

1189




                  CHAPTER 77                                            histocompatibility complex (MHC) class I or class II antigens. Thus,
                                                                        target-cell recognition by NK cells is distinct from cytotoxic T lym-
                  FUNCTIONS OF NATURAL                                  phocytes (CTLs), which recognize specific antigenic peptides bound to
                                                                        MHC class I molecules. Nonetheless, the presence of MHC class I on
                  KILLER CELLS                                          target cells affects NK cell recognition, in some cases inhibiting a NK
                                                                        cell response.
                                                                            Certain T lymphocytes that express either αβ or a γδ TCR may
                                                                        exhibit, particularly upon activation, TCR-independent cytolytic activ-
                  Giorgio Trinchieri, Richard W. Childs, and Lewis L. Lanier  ity that resembles that of NK cells and often express many of the same
                                                                        surface receptors as NK cells. Among the T lymphocytes in humans
                                                                        and mice that coexpress many of the NK cell antigens, invariant natu-
                                                                        ral killer T (iNKT) cells express an invariant TCR that recognizes gly-
                     SUMMARY                                            colipids presented by CD1d, a nonclassical MHC molecule, and upon
                                                                        stimulation rapidly produce large amounts of IFN-γ, granulocyte-mac-
                    Natural killer (NK) cells, with a predominant morphology of large granular   rophage colony-stimulating factor (GM-CSF), interleukin (IL)-4, and
                    lymphocytes, represent a lineage of lymphoid cells with constitutive ability to   IL-13. 4
                    mediate cytotoxicity toward pathologic target cells and secrete cytokines. NK
                    cells participate in the innate resistance to microbial pathogens and malignan-
                    cies; opposing effects of activating and inhibitory receptors regulate NK cell   MORPHOLOGY
                    activity. Malignant expansions of NK cells, either acute or chronic, are rare, but   Human LGLs are medium- to large-size  lymphocytes with round or
                    represent well-identified clinical entities.        indented nuclei, condensed chromatin, and usually prominent nucle-
                                                                        oli. The cytoplasm is abundant and contains a variety of organelles and
                                                                        granules (primary lysosomes) that, in addition to lysosomal enzymes,
                                                                        contain proteins important for cytotoxic function, such as serine
                        IDENTIFICATION AND DEFINITION                   esterases (granzymes) and pore-forming proteins (perforin).  Although
                                                                                                                    5
                                                                        many NK cells have the morphology typical of LGL, a significant pro-
                     OF NATURAL KILLER CELLS                            portion of NK cells are agranular and indistinguishable from other
                                                                        lymphocytes. 6
                  DEFINITION
                  Natural killer (NK) cells were identified in the blood and lymphoid
                  organs of humans and experimental animals as cells capable of killing   ORIGIN AND TISSUE DISTRIBUTION
                  tumors, virus-infected cells, and, in some instances, normal cells, in the   NK cells originate in the marrow from the common lymphoid progen-
                  absence of previous deliberate or known sensitization.  NK cells are   itor cell.  Most have a life span ranging from a few days to a few weeks,
                                                          1,2
                                                                              7
                                                                                                                           8
                  now considered to belong to the cellular subgroup that is characterized   but some may persist for months after exposure to viral challenge.  In
                                                                                                                         9
                  by the production of interferon (IFN)-γ within the family of innate lym-  mice, the cytokine IL-15 plays a particularly important role in the dif-
                  phoid cells (ILCs), a family of developmentally related cells involved   ferentiation and expansion of NK cells.  NK cell differentiation does
                                                                                                     10
                  in innate immunity and tissue development.  NK cells are defined as   not require the thymus, although NK cell progenitors can differentiate
                                                   3
                  cytotoxic cells with the predominant morphology of large granular   in the thymus from precursors expressing IL-7Rα CD127.  Second-
                                                                                                                    11
                  lymphocytes (LGLs) that: (1) neither productively rearrange any of   ary lymphoid tissues may also be a site of NK cell development in
                  the genes encoding the T-cell receptor (TCR) chains nor express on   humans.  The increased number of NK cells and altered anatomical
                                                                               12
                  their surface the CD3-TCR complex; (2) express the CD56 (N-CAM),   distribution in response to infection or other stimuli are the result
                  CD335 (NKp46), and CD16 (FcγRIIIA), antigens in humans, the NK1.1   of increased NK cell production in the marrow and proliferation of
                  (NKR-P1C), NKp46, and DX5 (VLA-2/CD49d) antigens in mice, and   peripheral NK cells.
                  the NKR-P1 antigen in rats; and (3) can kill cells not expressing major   NK cells represent approximately 5 to 20 percent of blood lympho-
                                                                        cytes.  Immature NK cells express high amounts of CD56, lack CD16,
                                                                            13
                                                                        and have low cytolytic capacity, whereas mature NK cells in blood
                                                                        express low amounts of CD56, high levels of CD16, and mediate potent
                                                                                 14
                    Acronyms and Abbreviations:  ADCC, antibody-dependent cell-mediated   lytic activity.  NK cells are present in the red pulp of the spleen and are
                                                                                                                        2
                    cytotoxicity; AML, acute myelogenous leukemia; CAR, chimeric antigen   found at a low frequency in other lymphoid organs and marrow.  NK
                    receptor;  CTL, cytotoxic T lymphocyte; GM-CSF, granulocyte-macrophage   cells with a phenotype resembling the CD56 high  peripheral subset have
                                                                                              15
                    colony-stimulating factor; HLA, human leukocyte antigen; IFN, interferon;   been detected in lymph nodes.  Small numbers of NK cells can be iden-
                    Ig, immunoglobulin; IL, interleukin; ILC, innate lymphoid cell; iNKT, invari-  tified in the liver (pit cells), lung, and intestinal mucosa. 16,17  In response
                    ant natural killer T cell; ITIM, immunoreceptor tyrosine-based inhibitory   to type I IFN or viral or bacterial infections, NK cells accumulate in
                                                                        organs in which they normally are rare, particularly the liver, marrow,
                    motif; KIR, killer cell Ig-like receptor; LCMV, lymphocytic choriomeningitis   and lymph nodes where they may produce large amounts of cytokines.
                                                                                                                          18
                    virus; LGL, large granular lymphocyte; MCMV, mouse cytomegalovirus; MHC,   CD56 bright  CD16  NK cells are the predominant cell type present in the
                                                                                    –
                    major histocompatibility complex; NK, natural killer; TCR, T-cell antigen   human early pregnancy decidua.  Decidual NK cells produce cytokines
                                                                                                19
                    receptor; TNF, tumor necrosis factor; TRAIL, TNF-related apoptosis-inducing   that have tissue remodeling capacity, facilitate embryonic implantation,
                    ligand.                                             monitor mucosal integrity throughout the menstrual cycle, control
                                                                        trophoblast invasion during pregnancy, and modulate the maternal
                                                                        immune response against embryo antigens. 19



          Kaushansky_chapter 77_p1189-1194.indd   1189                                                                  9/21/15   11:22 AM
   1209   1210   1211   1212   1213   1214   1215   1216   1217   1218   1219